Marc Giovannini, Lopes Cesar Vivian
Endoscopic Unit, Paoli-Calmettes Institute, 232 Bd. St-Marguerite, Cedex 13273, France.
World J Gastroenterol. 2008 Aug 7;14(29):4600-6. doi: 10.3748/wjg.14.4600.
Therapeutic endoscopy plays a major role in the management of gastrointestinal (GI) neoplasia. Its indications can be generalized into four broad categories; to remove or obliterate neoplastic lesion, to palliate malignant obstruction, or to treat bleeding. Only endoscopic resection allows complete histological staging of the cancer, which is critical as it allows stratification and refinement for further treatment. Although other endoscopic techniques, such as ablation therapy, may also cure early GI cancer, they can not provide a definitive pathological specimen. Early stage lesions reveal low frequency of lymph node metastasis which allows for less invasive treatments and thereby improving the quality of life when compared to surgery. Endoscopic mucosal resection (EMR) and endoscopic submucosal dissection (ESD) are now accepted worldwide as treatment modalities for early cancers of the GI tract.
治疗性内镜检查在胃肠道肿瘤的管理中发挥着重要作用。其适应证可大致分为四大类:切除或消除肿瘤性病变、缓解恶性梗阻或治疗出血。只有内镜切除术能够对癌症进行完整的组织学分期,这一点至关重要,因为它有助于进一步治疗的分层和优化。尽管其他内镜技术,如消融治疗,也可能治愈早期胃肠道癌症,但它们无法提供明确的病理标本。早期病变显示淋巴结转移频率较低,与手术相比,这使得可以采用侵入性较小的治疗方法,从而提高生活质量。内镜黏膜切除术(EMR)和内镜黏膜下剥离术(ESD)目前在全球范围内被公认为胃肠道早期癌症的治疗方式。